AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 31 min read$DOCS

Wampler Kira Scherer sold $53K of DOCS

Wampler Kira Scherer sold 2,000 shares of Doximity, Inc. (DOCS) at $26.33 on 2026-09-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Wampler Kira Scherer
Published Sep 3, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2026, 7:12 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$DOCS
Neutral
high confidence
Mentioned
$DOCS
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DOCSNeutralLow
01

Why it matters

The sale is small and pre‑arranged, offering little new insight into company fundamentals.

02

Market read

Limited relevance; the transaction is unlikely to affect Doximity's stock price or sector outlook.

03

What to watch

Potential upcoming compensation changes or stock dilution not disclosed.

Relevance 2/10Novelty 3/10Timing: post‑market filing on Sep 3, 2026

Background

Form 4 filing discloses insider transactions required by the SEC; this is the first public report of the sale.

Company-level read

Ticker impact

$DOCSNeutralHigh confidence
Context

Director Kira Scherer sold 2,000 shares for $52,660 via a 10b5‑1 plan, reducing her stake to 27,923 shares.

Expected impact

minimal impact, price likely to stay within current range

Evidence & confidence

The transaction size is modest relative to market cap and was pre‑arranged, so it carries limited informational value for traders.

Market effects

Sector

No significant effect on the healthcare staffing sector.

Regional

Limited to U.S. investors; no regional ripple.

Global

None

Counterpoint

What could challenge this read

Some traders view any insider sell as a bearish signal, but the size and 10b5‑1 plan dilute that view.

Key entities

  • company
    Doximity, Inc.

    U.S. professional networking platform for physicians (ticker DOCS).

  • insider
    Kira Scherer Wampler

    Director of Doximity who sold shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

DOCS insider trading history →

Related articles

SEP 14
MedAI 8/10

Doximity’s ex-chief revenue officer to pay nearly $500K to SEC: Trial Balance

Doximity's former chief revenue officer, Paul Jorgensen, was ordered to pay $490,000 to the SEC for insider trading. He sold shares based on nonpublic information ahead of negative earnings announcements, avoiding losses and making $2.2 million in profits. Jorgensen was also sentenced to 26 months in prison and ordered to forfeit $2.5 million in a parallel criminal case.

finance.yahoo.com2 min
SEP 8
$DOCSMed

Doximity stock falls as Freedom Capital cuts to hold

Doximity Inc (DOCS) shares dropped 5.6% after Freedom Capital downgraded it to Hold, raising its price target to $27. The company beat Q1 estimates, increased full-year revenue guidance, but lowered EBITDA outlook due to AI investment. Freedom Capital noted strong AI search traction but margin concerns and core business softening.

investing.com1 min
AUG 16
$DOCSMedAI 8/10

Doximity (DOCS) Q1 2027 Earnings Call Transcript

Doximity (DOCS) reported Q1 2027 revenue of $156.6 million, up 7% year over year, and adjusted EBITDA of $74.8 million. The company raised full-year 2027 revenue guidance to $671 million to $681 million. It said AI workflow and scribe usage grew, repurchased $91.6 million of stock, and ended June 30 with $688 million in cash and marketable securities.

aol.com6 min
AUG 14
$DOCSMedAI 8/10

Doximity (DOCS) Q1 2027 Earnings Call Transcript

Doximity (DOCS) reported Q1 FY2027 revenue of $156.6 million, up 7% year over year, with adjusted EBITDA of $74.8 million. The company raised full-year 2027 revenue guidance to $671 million to $681 million and adjusted EBITDA guidance to $309 million to $329 million. It also repurchased $91.6 million of stock and ended June 30 with $688 million cash and marketable securities.

fool.com7 min
AUG 11
$DOCSMed

Doximity Stock Surges in Overnight Trading as Chief Executive Highlights High-Margin AI Tool

Doximity (DOCS) shares jumped in overnight trading after CEO Jeffrey Tangney said the company’s new AI search tool generates over 10 times the revenue versus its operating cost. The stock later closed up 33% on Friday. Doximity reported Q1 revenue of $156.6M and adjusted EBITDA of $74.8M, and raised full-year guidance to $671M-$681M. Wells Fargo later downgraded to underweight.

tikr.com6 min